Summary
Biogen Idec Inc. (BIIB) filed an 8-K on October 22, 2014, to report its third-quarter 2014 financial results. The primary purpose of this filing is to provide investors with updated operational and financial performance data. Investors should pay close attention to the details within the furnished press release (Exhibit 99) for specifics on revenue, profitability, and any forward-looking statements or business developments announced during the quarter. While this filing itself is informational, the underlying press release contains the crucial data for assessing the company's performance and outlook.
Key Highlights
- 1Biogen Idec announced its third-quarter 2014 financial results on October 22, 2014.
- 2The company issued a press release detailing its operational and financial condition for the quarter ended September 30, 2014.
- 3This information was furnished as Exhibit 99 to the 8-K filing.
- 4The press release contains key performance indicators for the third quarter.
- 5Investors should refer to Exhibit 99 for detailed financial and operational data.
- 6The information furnished is not deemed 'filed' for regulatory purposes under Section 18 of the Exchange Act.
Frequently Asked Questions
The main purpose of this 8-K filing is to report Biogen Idec's financial results and operational performance for the third quarter ended September 30, 2014, through a furnished press release.
The specific financial details for the third quarter are located in the press release furnished as Exhibit 99 to this 8-K filing.
This 8-K filing itself primarily serves to report financial results. Any new business updates or strategic information would typically be found within the content of the press release (Exhibit 99) that is incorporated by reference.
The statement means that the press release is being provided for informational purposes and is not subject to the same liability provisions under Section 18 of the Securities Exchange Act of 1934 as if it were formally 'filed' with the SEC. It also clarifies that the information is not automatically incorporated into other SEC filings by reference.